{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:03:58Z","timestamp":1793865838060,"version":"4.6.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OFIL-24\\u2013074"],"award-info":[{"award-number":["OFIL-24\\u2013074"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.semarthrit.2026.153014","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:37:36Z","timestamp":1780501056000},"page":"153014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The OMERACT core domain sets for calcium pyrophosphate deposition disease"],"prefix":"10.1016","volume":"79","author":[{"given":"Nicola","family":"Dalbeth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Hensey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Grossberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine M","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Pascart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustin","family":"Latourte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Cipolletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Diaz-Torne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim L","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lih En","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sirotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Becce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Filippou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder A.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Abhishek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2026.153014_bib0001","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/art.42962","article-title":"Features associated with different inflammatory phenotypes of calcium pyrophosphate deposition disease: a study using data from the International American college of rheumatology\/EULAR calcium pyrophosphate deposition classification criteria cohort","volume":"76","author":"Pascart","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0002","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/ard.2010.139105","article-title":"European league against rheumatism recommendations for calcium pyrophosphate deposition. part i: terminology and diagnosis","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0003","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/ard.62.6.513","article-title":"UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte","volume":"62","author":"Neame","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0004","first-page":"1241","article-title":"The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study","volume":"16","author":"Felson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0005","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/acr.24619","article-title":"Identifying potential classification criteria for calcium pyrophosphate deposition disease: item generation and item reduction","volume":"74","author":"Tedeschi","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0006","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/acr.21952","article-title":"Evidence of a systemic predisposition to chondrocalcinosis and association between chondrocalcinosis and osteoarthritis at distant joints: a cross-sectional study","volume":"65","author":"Abhishek","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0007","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/gucdd3040022","article-title":"The fast-evolving landscape of treatments for calcium pyrophosphate deposition disease","volume":"3","author":"Tai","year":"2025","journal-title":"Gout Urate Cryst Depos Dis"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0008","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/0003-4819-56-5-711","article-title":"The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the \"Pseudogout syndrome\"","volume":"56","author":"McCarty","year":"1962","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0009","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2665-9913(23)00136-4","article-title":"Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level","volume":"5","author":"Sirotti","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0010","article-title":"Which are the most frequently involved peripheral joints in calcium pyrophosphate crystal deposition at imaging? A systematic literature review and meta-analysis by the OMERACT ultrasound - CPPD subgroup","volume":"10","author":"Adinolfi","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0011","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/annrheumdis-2017-212542","volume":"77","author":"Filippou","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0012","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3899\/jrheum.161057","article-title":"Definition and reliability assessment of elementary ultrasonographic findings in calcium pyrophosphate deposition disease: a study by the OMERACT calcium pyrophosphate deposition disease ultrasound subtask Force","volume":"44","author":"Filippou","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0013","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3899\/jrheum.181097","article-title":"Core domain set selection according to OMERACT filter 2.1: the OMERACT methodology","volume":"46","author":"Maxwell","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0014","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","article-title":"Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0","volume":"67","author":"Boers","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0015","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3899\/jrheum.181096","article-title":"OMERACT filter 2.1: elaboration of the Conceptual framework for outcome measurement in Health intervention studies","volume":"46","author":"Boers","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0016","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.semarthrit.2021.04.019","article-title":"Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: a framework paper by the OMERACT CPPD working group","volume":"51","author":"Cai","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0017","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.semarthrit.2020.05.015","article-title":"Outcome domains reported in calcium pyrophosphate deposition studies: a scoping review by the OMERACT CPPD working group","volume":"50","author":"Cai","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0018","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.semarthrit.2021.04.010","article-title":"Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: a qualitative exploration from the OMERACT CPPD working group","volume":"51","author":"Fuller","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0019","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.semarthrit.2020.09.021","article-title":"Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): a content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group","volume":"51","author":"Fuller","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0020","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3899\/jrheum.181194","article-title":"The OMERACT-OARSI core domain set for measurement in clinical trials of hip and\/or knee osteoarthritis","volume":"46","author":"Smith","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0021","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3899\/jrheum.141017","article-title":"Report from the OMERACT hand osteoarthritis working group: set of core domains and preliminary set of instruments for use in clinical trials and observational studies","volume":"42","author":"Kloppenburg","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0022","article-title":"Core domain set for chronic and\/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus","volume":"72","author":"Zhang","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0023","article-title":"Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus","volume":"72","author":"Zhang","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152423","article-title":"Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets","volume":"66","author":"Maxwell","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/ard-2023-224575","article-title":"The 2023 ACR\/EULAR classification criteria for calcium pyrophosphate deposition disease","volume":"82","author":"Abhishek","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153014_bib0026","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.semarthrit.2021.08.011","article-title":"The evolution of instrument selection for inclusion in core outcome sets at OMERACT: filter 2.2","volume":"51","author":"Maxwell","year":"2021","journal-title":"Semin Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:25:29Z","timestamp":1785903929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"alternative-id":["S0049017226001046"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153014","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The OMERACT core domain sets for calcium pyrophosphate deposition disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153014"}}